Patent · US Active

Antibody and uses thereof

US8747849B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Fusion Antibodies Limited · IE

Inventors

Christopher Scott · Foxford, IE
Roberta Burden · Foxford, IE
Shane Olwill · Freising, DE
Brian Walker · New Philadelphia, US
Jim Johnston · Foxford, IE

Key dates

Filing date	Mar 18, 2011
Grant date	Jun 10, 2014
Priority date	—
Expiry date	Mar 18, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are specific binding members e.g. antibodies which may be used in the treatment of diseases associated with cathepsin S activity. The specific binding members bind cathepsin S and inhibit its proteolytic activity. The binding members may be used in the treatment of diseases such as cancer, inflammatory diseases, neurodegenerative disorders, autoimmune disorders, and other diseases associated with excessive, deregulated or inappropriate angiogenesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.